eli lilly acquisition - Stock Newsroom

S TOCK newsroom .COM

S&P 500 7,585 +0.03%

DJIA 51,042 +0.57%

Nasdaq 30,350 +0.23%

DAX 25,052 -0.22%

Gold $4,196 +0.16%

Oil $87.81 -0.77%

BTC $73,629 +0.08%

VIX 17.63 -1.26%

EUR/USD 1.1785 -0.02%

ETH $2,017 +0.19%

S&P 500 7,585 +0.03%

DJIA 51,042 +0.57%

Nasdaq 30,350 +0.23%

DAX 25,052 -0.22%

Gold $4,196 +0.16%

Oil $87.81 -0.77%

BTC $73,629 +0.08%

VIX 17.63 -1.26%

EUR/USD 1.1785 -0.02%

ETH $2,017 +0.19%

eli lilly acquisition

Stocks

Eli Lilly Acquisition Boom: $2.3B Ajax Oncology Shock

By Maik Kemper • Apr 29, 2026

Eli Lilly Acquisition research team working on in-vivo CAR-T cancer and GLP-1 therapy in advanced biotech lab

Stocks

Eli Lilly Acquisition Boom: Multi‑Billion Cancer and Obesity Bet

By Maik Kemper • Apr 20, 2026

Video

Stocks

Eli Lilly Acquisition Boom: $2.3B Ajax Oncology Shock

By Maik Kemper • Apr 29, 2026

Is the latest Eli Lilly Acquisition of Ajax Therapeutics a smart oncology pivot or a risky $2.3 billion side bet? Maik Kemper Editor in Chief…

Video

Stocks

Eli Lilly Acquisition Boom: Multi‑Billion Cancer and Obesity Bet

By Maik Kemper • Apr 20, 2026

Can the latest Eli Lilly Acquisition in next‑gen cancer therapy really justify its sky‑high valuation beyond the obesity drug boom? Maik Kemper Editor in Chief…